Skip to main content

Advertisement

Figure 5 | Malaria Journal

Figure 5

From: Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations

Figure 5

Competition immunofluorescence staining of in vitro cultivated P. falciparum schizonts with recombinant GMZ2, MSP3 or GLURP. Parasites were stained with anti-GMZ2 immune serum of a NMRI mouse pre-incubated without or with recombinant competitors. Immune serum was used at a dilution of 1:1000 and competitors at a concentration of 10 μg/mL. Nuclei were visualized using DAPI staining.

Back to article page